NeuroX1 Inc.

NeuroX1 Inc.

生物技术研究

Austin,TX 1,897 位关注者

Creating the next generation of therapeutics for neurodegenerative disorders with our proprietary generative AI platform

关于我们

NeuroX1 is developing a target ID and drug discovery platform leveraging proprietary generative AI algorithms to create the next generation of therapeutics for neurological disorders. Our early-stage pipeline consists of several pre-clinical assets partnered with a variety of pharma companies and institutions.

网站
https://www.neurox1.com
所属行业
生物技术研究
规模
2-10 人
总部
Austin,TX
类型
私人持股
创立
2021
领域
generative drug discovery、biotechnology、neurology、neurodegenerative、rare disease、pediatric rare disease、AI、neuroscience、cancer、brain、generativeAI、Alzheimer's、Parkinson's、preclinical、MS、big pharma、partnerships、target ID、generative drugs、novel drugs、novel small molecules、future of drug discovery、inhibitors、neurosurgery、neural networks、platform technology、drug discovery platform、computational chemistry、computational biology和target discovery

地点

NeuroX1 Inc.员工

动态

相似主页

查看职位

融资

NeuroX1 Inc. 共 3 轮

上一轮

种子轮

US$220,000.00

Crunchbase 上查看更多信息